Section 5: Patient Safety and Quality Assurance

5PSQ-015

PRESCRIPTION ERRORS OF ANTICOAGULANTS

5PSQ-007

ASSESSMENT OF THE INTERVENTION OF THE GROUP PROI ENDOCRINOLOGY-PHARMACY FOR THE IMPROVEMENT OF INSULIN THERAPY IN THE HOSPITAL

5PSQ-002

ADHERENCE TO GUIDELINES FOR TREATMENT OF UPPER AND LOWER GASTROINTESTINAL BLEEDING IN ACUTE SURGICAL WARDS

5PSQ-111

IMPROVING PATIENT SAFETY AND QUALITY ASSURANCE THROUGH MULTIDISCIPLINARY CLINICAL AUDITS

5PSQ-108

REDUCING ERRORS OF ORAL MEDICATION ADMINISTRATION IN PATIENTS WITH DYSPHAGIA

5PSQ-090

LACK OF ISO-APPEARANCE IN DISPENSED ANTIPSYCHOTICS IN PATIENTS WITH SCHIZOPHRENIA

5PSQ-075

FINGOLIMOD-ASSOCIATED LYMPHOPAENIA IN MULTIPLE SCLEROSIS PATIENTS

5PSQ-070

HAZARDOUS DRUGS DISPENSED TO OUTPATIENTS AND PROPOSALS FOR SAFE HANDLING

5PSQ-059

TOXICITY ASSOCIATED WITH THE USE OF NIVOLUMAB IN MONOTHERAPY IN CLINICAL PRACTICE

5PSQ-054

DRUGS THAT EXTEND THE QT INTERVAL OF THE ECG: EVALUATION OF ONCOLOGICAL PATIENTS

5PSQ-051

EFFECTIVENESS AND SAFETY OF SNAKE ANTIVENOM: A CASE REPORT

5PSQ-047

SERIOUS ADVERSE REACTIONS AND SUSTAINED VIRAL RESPONSE RELATED TO 3D REGIME: PURPOSE OF A CASE

5PSQ-044

SYSTEMIC ADMINISTRATION OF ANTIFUNGAL MEDICINES: ANALYSIS OF PRESCRIPTIONS

5PSQ-039

ANALYSIS OF THE QUALITY OF THE INFORMATION REGISTERED IN THE ELECTRONIC MEDICAL RECORD FOR THE CORRECT FOLLOW-UP OF THE TREATMENT WITH VANCOMYCIN

5PSQ-030

USE AND EFFECTIVENESS OF TIGECYCLINE IN A PRIVATE CARE HOSPITAL

Pages